Table: Hisamitsu - 9-MTH group results

Hisamitsu Pharmaceutical Co

11/01/2024 06:00

Jan 11 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Nov 30, 2023        Nov 30, 2022     Feb 29, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              102.83               91.88           141.00    
                   (+11.9 pct)         (+6.0 pct)       (+9.9 pct)  
  Operating           12.27                8.51            14.40    
                   (+44.2 pct)         (+22.0 pct)      (+24.1 pct) 
  Recurring           16.66               13.00            19.90    
                   (+28.1 pct)         (+50.1 pct)      (+24.0 pct) 
  Net                 12.11                9.52            14.60    
                   (+27.2 pct)         (+53.1 pct)      (+24.3 pct) 
  EPS              156.64 yen          119.46 yen       188.85 yen  
  EPS Diluted      156.48 yen          119.36 yen                   
  Ann Div                               84.50 yen        85.00 yen  
  -Q2 div           42.50 yen           42.25 yen                   
  -Q4 div                               42.25 yen        42.50 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T